[Bladder contracture following intravesical BCG immunotherapy treated by hydrodistention: a case report].
A 35-year-old man had undergone retroperitoneoscopic radical nephrouretectomy in May 2002 (pTisNxM0). He later developed carcinoma in situ (CIS) of the bladder, and underwent intravesical instillation of 80 mg of Bacillus-Calmette-Guerin (BCG) once a week for 6 weeks in January 2004. After the treatment, irritative symptoms (frequency and dysuria) developed, and he was diagnosed with bladder contracture. Conventional treatment with anti-cholinergics, analgesics, anti-tuberculous drugs, and steroids was ineffecsive, but hydrodistention improved the subjective symptoms. Hydrodistention seems to be useful for bladder contracture following intravesical BCG immunotherapy.
Sawada
Atsuro
A
Department of Urology, Shimada Municipal Hospital.
Yagihashi
Yuusuke
Y
Kawase
Norio
N
Fukuzawa
Shigeki
S
D000283:Administration, Intravesical; D000328:Adult; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D002278:Carcinoma in Situ / Q000628:therapy; D003286:Contracture / Q000628:therapy*; D004106:Dilatation; D006801:Humans; D006874:Hydrostatic Pressure; D016233:Immunotherapy, Active / Q000009:adverse effects*; D008297:Male; D001743:Urinary Bladder; D001749:Urinary Bladder Neoplasms / Q000628:therapy
D001500:BCG Vaccine